参考文献/References:
1 Pena LA,Fuks Z,Kolesnick RN.Radiation-induced apoptosis of endothelial cells in the murine central nervous system:protection by fibroblast growth factor and sphingomyelinase deficiency[J].Cancer Res,2000,60(2):321-327.
2 Kimura T,Sako K,Tohyama Y,et al.Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis:value of proton magnetic resonance spectroscopy[J].Acta Neurochir (Wien),2003,145(7):557-564.
3 Kutita H,Kawahara N,Asai A,et al.Radiation-induced apoptosis of oligodendrocytes in the adult rat brain[J].Neurol Res,2001, 23(8):869-874.
4 Nieder C,Andratschke N,Price RE,et al.Innovative prevention strategies for radiation necrosis of the central nervous system[J].Anticancer Res,2002,22(2A):1017-1023.
5 New P.Radiation injury to the nervous system[J].Curr Opin Neurol,2001,14(6):725-734.
6 Schlemmer HP,Bachert P,Henze M,et al.Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy[J].Neuroradiology,2002,44(3):216-222.
7 Schlemmer HP,Bachert P,Herfarth KK,et al.Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic ra-diotherapy[J].Am J Neuroradiol,2001,22(7):1316-1324.
8 Langleben DD,Segall GM.PET in differentiation of recurrent brain tumor from radiation injury[J].J Nucl Med,2000,41(11):1861-1867.
9 Wong WC,Cheng PW,Chan FL,et al.Improved diagnosis of a temporal lobe abscess in a post-irradiated nasopharyngeal carcinoma patient using diffusion-weighted magnetic resonance imaging[J].Clin Radiol,2002,57(11):1040-1043.
10 Tandon N,Vollmer DG,New PZ,et al.Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa[J].J Neurosurg,2001,95(3):507-512.
11 Kim SH,Lim DJ,Chung YG,et al.Expression of TNF-alpha and TGF-beta1 in the rat brain after a single high-dose irradiation[J].J Korean Med Sci,2002,17(2):242-248.
12 Nieder C,Price RE,Rivera B,et al.Both early and delayed treatment with growth factors can modulate the development of radiation myelopathy (RM) in rats[J].Radiother Oncol,2000,56(suppl 1):15-17.
13 Chuba PJ,Aronin P,Bhambhani K,et al.Hyperbaric oxygen therapy for radiation-induced brain injury in children[J].Cancer,1997,80(10):2005-2012.
14 Sminia P,van der Kleij AJ,Carl UM,et al.Prophylactic hyperbaric oxygen treatment and rat spinal cord re-irradiation[J].Cancer Lett,2003,191(1):59-65.
15 Sheikh AY,Gibson JJ,Rollins MD,et al.Effect of hyperoxia on vascular endothelial growth factor levels in a wound model[J].Arch Surg,2000,135(11):1293-1297.
16 Kohshi K,Imada H,Nomoto S,et al.Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy[J].J Neurol Sci,2003,209(1-2):115-117.
17 Malone S,Raaphorst GP,Gray R,et al.Enhanced in vitro radiosensitivity of skin fibroblasts in two patients developing brain necrosis following AVM radiosurgery:a new risk factor with potential for a predictive assay[J].Int J Radiat Oncol Biol Phys,2000,47(1):185-189.
18 Rezvani M,Birds DA,Hodges H,et al.Modification of radiation myelopathy by the transplantation of neural stem cells in the rat[J].Radiat Res,2001,156(4):408-412.
相似文献/References:
[1]邱新峰,刘强.鼻咽癌放疗致放射性脑损伤的临床分析[J].国际放射医学核医学杂志,2008,32(3):191.
[2]姜炜.血管的辐射损伤[J].国际放射医学核医学杂志,2005,29(1):37.
JIANG Wei.Radiation injury of blood vessels[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):37.
[3]袁志斌.89Sr及联合治疗转移性骨肿瘤的临床应用[J].国际放射医学核医学杂志,2005,29(2):53.
YUAN Zhi-bin.The clinical application of strontium-89 concomitant use with other modalities in the treatment of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):53.
[4]盛晓芳,管一晖,赵军,等.PET-CT在脑胶质瘤放射治疗靶区确定中的应用[J].国际放射医学核医学杂志,2005,29(6):241.
SHENG Xiao-fang,GUAN Yi-hui,ZHAO Jun,et al.Application of PET-CT in delineation of radiotherapy planning target volume for glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):241.
[5]郑爱青,于金明.对乏氧和射线应答的嵌合性基因启动子的研究进展[J].国际放射医学核医学杂志,2004,28(2):74.
ZHENG Ai-qing,YU Jin-ming.Development of chimeric gene promoters responsive to hypoxia and ionizing radiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):74.
[6]张永权,巴特尔,刘文力.多发性脑转移瘤的立体定向伽玛刀治疗[J].国际放射医学核医学杂志,2004,28(2):94.
Zhang Yong-quan,Bateer,Liu Wen-li.The treatment on multiple brain metastasis by stereotactic gamma knife[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):94.
[7]陈再君,蒋宁一.131I治疗甲亢后致甲减的研究变迁[J].国际放射医学核医学杂志,2004,28(4):153.
CHEN Zai-jun,JIANG Ning-yi.The research vicissitudes of hypothyroidism after 131I therapy for hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):153.
[8]李诗运.131I治疗甲亢后甲减的综合预防和处理措施[J].国际放射医学核医学杂志,2004,28(4):157.
LI Shi-yun.Synthetic prevention and treatment for hypothyroidism after rdioiodine therapy hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):157.
[9]刘光伟,龚守良.siRNA与肿瘤放射治疗[J].国际放射医学核医学杂志,2004,28(4):169.
LIU Guang-wei,GONG Shou-liang.siRNA and tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):169.
[10]陆克义,李险峰.甲状腺疾病患者131I治疗后对他人的辐射危害评价[J].国际放射医学核医学杂志,2004,28(5):226.
LU Ke-yi,LI Xian-feng.Evaluation of radiation exposure from patients with thyroid disease by 131I therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):226.